Pilot Assessment of Lopinavir/Ritonavir and Maraviroc

Stopped early · Phase 4

Conditions studied: HIV Infections, Acquired Immunodeficiency Syndrome

In brief

This is a study to assess the response of lopinavir/ritonavir plus maraviroc (with no nucleoside medications) in HIV patients failing their initial antiviral therapy.

Key facts

Study ID

NCT00981318

Run by

Rodwick, Barry M., M.D.

People needed

3

Starts

2009-12-01

Expected to finish

2015-05-01

Last updated by the study team

2015-06-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV viral load > 1,000 on current antiviral medications
• No resistance to study medications
• Over 18 years of age

You may not qualify if…

• Hepatitis B co-infection
• Pregnancy
• Previous therapy with either of the study medications
• Ongoing substance abuse
• Significant history of other physical disease

Where it is running

• Barry M. Rodwick, M. D. — Safety Harbor, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.